Login
Password
Remember Me
AskBio Strengthens its Gene Therapy Technology Portfolio Asklepios Biopharmaceutical (AskBio), a US clinical-stage gene therapy platform company dedicated to rare genetic disorders,...
New CDMO acquisition for Keensight Capital Keensight Capital, a leading Paris-based private equity managers dedicated to pan-European Growth Buyout investments, has...
New collaboration to “silence” the complement cascade Mallinckrodt and Silence Therapeutics will collaborate to develop and commercialize RNAi drug targets designed to...
More articles from NEWS
Antibiotic development increased, but still insufficient While the pipeline of new antibiotics has improved over the past six years, momentum in...
Digital fusion: how smart collaborations will drive the healthcare revolution Convergence of digital technology and healthcare – digital health – has...
The International Society for Cell and Gene Therapy (ISCT), the global professional society of clinicians, researchers, regulatory specialists, technologists and industry...
More Articles from ANALYZES
Rescue, a new CRISPR platform to expand RNA editing capabilities The new system, dubbed RESCUE, allows RNA edits to be made...
New prospects for liquid biopsies ? Dr Muneesh Tewari, professor of internal medicine at the U-M Medical School. © Joseph XU. U-M College...
Illustration of lymphocytes attacking cancer cells.©La Jolla Institute How to counteract T cell exhaustion in CAR T cancer therapies? In...
More Articles from SCIENTIFIC NEWS
